Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Resectable Pancreatic Cancer 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Adenocarcinoma 1

Interventions

Oxaliplatin 137Fluorouracil 129Gemcitabine 114Bevacizumab 111Specimen Handling 102Leucovorin 101Capecitabine 90Magnetic Resonance Spectroscopy 81pembrolizumab 79Cisplatin 75Nivolumab 72Irinotecan 68130-nm albumin-bound paclitaxel 59durvalumab 58Cetuximab 58Paclitaxel 57Biopsy 56atezolizumab 42Radiotherapy 41Taxes 36Albumin-Bound Paclitaxel 36Folfox protocol 34Carboplatin 34Cyclophosphamide 29Drug Therapy 28lenvatinib 27tislelizumab 26sintilimab 26dehydroftorafur 26Radiation 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
paricalcitol × Gastrointestinal × 90 days × Clear all
NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Fox Chase Cancer Center

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT03415854 2026-05-12

NABPLAGEMD

HonorHealth Research Institute

Phase 2 Completed
34 enrolled 11 charts
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT03138720 2026-04-22

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

HonorHealth Research Institute

Phase 2 Completed
40 enrolled 22 charts
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡